Effect of Roflumilast at Acute Exacerbations of Chronic Obstructive Pulmonary Disease

PHASE2TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions

Chronic Obstructive Pulmonary Disease With (Acute) Exacerbation

Interventions

DRUG

Roflumilast

500 µg tablet, od, oral administration in the morning after breakfast

DRUG

Placebo

tablet, od, oral administration in the morning after breakfast

Trial Locations (2)

Academic Unit of Respiratory Medicine, Royal Free Hospital, Jadwiga A. Wedzicha, London

London